Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Cheifetz

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
The American Journal of Gastroenterology|April 30, 2021
Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc AnalysisKonstantinos Papamichael, Niels Vande Casteele, Jenny Jeyarajah, et al.
Digestive Diseases and Sciences|December 16, 2016
Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full ManuscriptsJoseph D Feuerstein, Priya Sehgal, Varun Rao, et al.
Digestive Diseases and Sciences|October 15, 2014
Documented compliance with inflammatory bowel disease quality measures is poorJoseph D Feuerstein, Jeffrey J Lewandowski, Manuel Martinez-Vazquez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2022
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Niels Vande Casteele, Bincy P Abraham, et al.
Inflammatory Bowel Diseases|April 21, 2017
Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel DiseaseKristin E Burke, Miriam J Haviland, Michele R Hacker, et al.
Inflammatory Bowel Diseases|April 9, 2016
Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose ImmunosuppressionSharmeel K Wasan, Samantha Zullow, Adam Berg, et al.
The American Journal of Gastroenterology|January 9, 2013
A random urine test can identify patients at risk of mesalamine non-adherence: a prospective studyAnne E Gifford, Anders H Berg, Conor Lahiff, et al.
Gastrointestinal Endoscopy|April 23, 2019
Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancerJoseph D Feuerstein, Shana Rakowsky, Lindsey Sattler, et al.
The American Journal of Gastroenterology|July 20, 2006
The risk of retention of the capsule endoscope in patients with known or suspected Crohn's diseaseAdam S Cheifetz, Asher A Kornbluth, Peter Legnani, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective studyAlan C Moss, Nabeel Chaudhary, Melissa Tukey, et al.
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
The American Journal of Gastroenterology|April 30, 2021
Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc AnalysisKonstantinos Papamichael, Niels Vande Casteele, Jenny Jeyarajah, et al.
Digestive Diseases and Sciences|December 16, 2016
Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full ManuscriptsJoseph D Feuerstein, Priya Sehgal, Varun Rao, et al.
Digestive Diseases and Sciences|October 15, 2014
Documented compliance with inflammatory bowel disease quality measures is poorJoseph D Feuerstein, Jeffrey J Lewandowski, Manuel Martinez-Vazquez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2022
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Niels Vande Casteele, Bincy P Abraham, et al.
Inflammatory Bowel Diseases|April 21, 2017
Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel DiseaseKristin E Burke, Miriam J Haviland, Michele R Hacker, et al.
Inflammatory Bowel Diseases|April 9, 2016
Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose ImmunosuppressionSharmeel K Wasan, Samantha Zullow, Adam Berg, et al.
The American Journal of Gastroenterology|January 9, 2013
A random urine test can identify patients at risk of mesalamine non-adherence: a prospective studyAnne E Gifford, Anders H Berg, Conor Lahiff, et al.
Gastrointestinal Endoscopy|April 23, 2019
Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancerJoseph D Feuerstein, Shana Rakowsky, Lindsey Sattler, et al.
The American Journal of Gastroenterology|July 20, 2006
The risk of retention of the capsule endoscope in patients with known or suspected Crohn's diseaseAdam S Cheifetz, Asher A Kornbluth, Peter Legnani, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective studyAlan C Moss, Nabeel Chaudhary, Melissa Tukey, et al.
Pageof 21